Cargando…

Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses

INTRODUCTION: Alzheimer's disease (AD) patients are at risk of nutritional insufficiencies because of physiological and psychological factors. Recently, we showed the results of the meta-analyses indicating lower plasma levels of vitamins A, B(12), C, E, and folate in AD patients compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wilde, Martijn C., Vellas, Bruno, Girault, Elodie, Yavuz, Aysun Cetinyurek, Sijben, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651428/
https://www.ncbi.nlm.nih.gov/pubmed/29067348
http://dx.doi.org/10.1016/j.trci.2017.06.002
_version_ 1783272889864159232
author de Wilde, Martijn C.
Vellas, Bruno
Girault, Elodie
Yavuz, Aysun Cetinyurek
Sijben, John W.
author_facet de Wilde, Martijn C.
Vellas, Bruno
Girault, Elodie
Yavuz, Aysun Cetinyurek
Sijben, John W.
author_sort de Wilde, Martijn C.
collection PubMed
description INTRODUCTION: Alzheimer's disease (AD) patients are at risk of nutritional insufficiencies because of physiological and psychological factors. Recently, we showed the results of the meta-analyses indicating lower plasma levels of vitamins A, B(12), C, E, and folate in AD patients compared with cognitively intact elderly controls (controls). Now, additional and more extensive literature searches were performed selecting studies which compare blood and brain/cerebrospinal fluid (CSF) levels of vitamins, minerals, trace elements, micronutrients, and fatty acids in AD patients versus controls. METHODS: The literature published after 1980 in Cochrane Central Register of Controlled Trials, Medline, and Embase electronic databases was systematically analyzed using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines to detect studies meeting the selection criteria. Search terms used are as follows: AD patients, Controls, vitamins, minerals, trace elements, micronutrients, and fatty acids. Random-effects meta-analyses using a linear mixed model with correction for age differences between AD patients and controls were performed when four or more publications were retrieved for a specific nutrient. RESULTS: Random-effects meta-analyses of 116 selected publications showed significant lower CSF/brain levels of docosahexaenoic acid (DHA), choline-containing lipids, folate, vitamin B(12), vitamin C, and vitamin E. In addition, AD patients showed lower circulatory levels of DHA, eicosapentaenoic acid, choline as phosphatidylcholine, and selenium. CONCLUSION: The current data show that patients with AD have lower CSF/brain availability of DHA, choline, vitamin B(12), folate, vitamin C, and vitamin E. Directionally, brain nutrient status appears to parallel the lower circulatory nutrient status; however, more studies are required measuring simultaneously circulatory and central nutrient status to obtain better insight in this observation. The brain is dependent on nutrient supply from the circulation, which in combination with nutrient involvement in AD-pathophysiological mechanisms suggests that patients with AD may have specific nutritional requirements. This hypothesis could be tested using a multicomponent nutritional intervention.
format Online
Article
Text
id pubmed-5651428
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56514282017-10-24 Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses de Wilde, Martijn C. Vellas, Bruno Girault, Elodie Yavuz, Aysun Cetinyurek Sijben, John W. Alzheimers Dement (N Y) Review Article INTRODUCTION: Alzheimer's disease (AD) patients are at risk of nutritional insufficiencies because of physiological and psychological factors. Recently, we showed the results of the meta-analyses indicating lower plasma levels of vitamins A, B(12), C, E, and folate in AD patients compared with cognitively intact elderly controls (controls). Now, additional and more extensive literature searches were performed selecting studies which compare blood and brain/cerebrospinal fluid (CSF) levels of vitamins, minerals, trace elements, micronutrients, and fatty acids in AD patients versus controls. METHODS: The literature published after 1980 in Cochrane Central Register of Controlled Trials, Medline, and Embase electronic databases was systematically analyzed using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines to detect studies meeting the selection criteria. Search terms used are as follows: AD patients, Controls, vitamins, minerals, trace elements, micronutrients, and fatty acids. Random-effects meta-analyses using a linear mixed model with correction for age differences between AD patients and controls were performed when four or more publications were retrieved for a specific nutrient. RESULTS: Random-effects meta-analyses of 116 selected publications showed significant lower CSF/brain levels of docosahexaenoic acid (DHA), choline-containing lipids, folate, vitamin B(12), vitamin C, and vitamin E. In addition, AD patients showed lower circulatory levels of DHA, eicosapentaenoic acid, choline as phosphatidylcholine, and selenium. CONCLUSION: The current data show that patients with AD have lower CSF/brain availability of DHA, choline, vitamin B(12), folate, vitamin C, and vitamin E. Directionally, brain nutrient status appears to parallel the lower circulatory nutrient status; however, more studies are required measuring simultaneously circulatory and central nutrient status to obtain better insight in this observation. The brain is dependent on nutrient supply from the circulation, which in combination with nutrient involvement in AD-pathophysiological mechanisms suggests that patients with AD may have specific nutritional requirements. This hypothesis could be tested using a multicomponent nutritional intervention. Elsevier 2017-06-24 /pmc/articles/PMC5651428/ /pubmed/29067348 http://dx.doi.org/10.1016/j.trci.2017.06.002 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
de Wilde, Martijn C.
Vellas, Bruno
Girault, Elodie
Yavuz, Aysun Cetinyurek
Sijben, John W.
Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
title Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
title_full Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
title_fullStr Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
title_full_unstemmed Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
title_short Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
title_sort lower brain and blood nutrient status in alzheimer's disease: results from meta-analyses
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651428/
https://www.ncbi.nlm.nih.gov/pubmed/29067348
http://dx.doi.org/10.1016/j.trci.2017.06.002
work_keys_str_mv AT dewildemartijnc lowerbrainandbloodnutrientstatusinalzheimersdiseaseresultsfrommetaanalyses
AT vellasbruno lowerbrainandbloodnutrientstatusinalzheimersdiseaseresultsfrommetaanalyses
AT giraultelodie lowerbrainandbloodnutrientstatusinalzheimersdiseaseresultsfrommetaanalyses
AT yavuzaysuncetinyurek lowerbrainandbloodnutrientstatusinalzheimersdiseaseresultsfrommetaanalyses
AT sijbenjohnw lowerbrainandbloodnutrientstatusinalzheimersdiseaseresultsfrommetaanalyses